Published papers
Kubota, Naoto
1-20 items (total 43)
Immunohistochemical visualization of the signature of activated Hedgehog signaling pathway in cutaneous epithelial tumors.
- Author
- Tanese K, Emoto K, Kubota N, Fukuma M, Sakamoto M.
- Publication Title
- Magazine name J Dermatol Publisher John Wiley & Sons Australia, Ltd Volume 45(Issue 10) Start Page 1181 - End Page 1186 (Publication Date）2018/07）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
- ISSN
- 0385-2407
Landscape of immune microenvironment in hepatocellular carcinoma and its additional impact on histological and molecular classification.
- Author
- Kurebayashi Y, Ojima H, Tsujikawa H, Kubota N, Maehara J, Abe Y, Kitago M, Shinoda M, Kitagawa Y, Sakamoto M.
- Publication Title
- Magazine name Hepatology (Publication Date）2018/03）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
Immune microenvironment of hepatocellular carcinoma, intrahepatic cholangiocarcinoma and liver metastasis of colorectal adenocarcinoma: Relationship with histopathological and molecular classifications
- Author
- Kurebayashi Y, Kubota N, Sakamoto M
- Publication Title
- Magazine name Hepatology Research Publisher Hepatology Research Volume 51(Issue 1) Start Page 5 - End Page 18 (Publication Date）2021/01）
- Peer-review Status
- With
- ISSN
- 13866346
Figure S1-S5 from Activating an Adaptive Immune Response with a Telomerase-mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2024/09）
Figure S1-S5 from Activating an Adaptive Immune Response with a Telomerase-mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2024/09）
Figure S1-S5 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2025/11）
CPC解説 脾破裂をきたした芽球性形質細胞様樹状細胞腫瘍の1剖検例(症例検討会)
- Author
- 久保田 直人, 下田 将之, 江本 桂, 荒川 和清, 中間 楽平, 横倉 英人, 増田 義洋, 末盛 友浩, 眞杉 洋平
- Publication Title
- Magazine name 病理と臨床 Publisher 文光堂 Volume 36(Issue 4) Start Page 385 - End Page 390 (Publication Date）2018/04）
- Authorship Category
- Joint Work
- Publication Category
- Research paper (scientific journal)
- Peer-review Status
- With
- ISSN
- 0287-3745
Data from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2023/06）
Disseminative Recurrence Signature for Hepatocellular Carcinoma From Nonalcoholic Fatty Liver Disease.
- Author
- Fujiwara N., Kubota N., Zhu S., Nakagawa S., Baba H., Hoshida Y.
- Publication Title
- Magazine name Gastro hep advances Volume 2(Issue 5) Start Page 681 - End Page 683 (Publication Date）2023）
Epstein-Barr virus-associated inflammatory pseudotumor variant of follicular dendritic cell sarcoma of the liver: a case report and review of the literature.
- Author
- Abe K., Kitago M., Matsuda S., Shinoda M., Yagi H., Abe Y., Oshima G., Hori S., Endo Y., Yokose T., Miura E., Kubota N., Ueno A., Masugi Y., Ojima H., Sakamoto M., Kitagawa Y.
- Publication Title
- Magazine name Surgical case reports Volume 8(Issue 1) Start Page 220 (Publication Date）2022/12）
- ISSN
- 2198-7793
FDG-PET/CTの集積で診断され術中の局所診断に苦慮した非機能性膵神経内分泌腫瘍(PNET)の1切除例 病変の術中検出限界、ピットフォールについて
- Author
- 竹村 裕介, 北郷 実, 板野 理, 篠田 昌宏, 八木 洋, 阿部 雄太, 大島 剛, 堀 周太郎, 藤田 優裕, 益田 悠貴, 久保田 直人, 辻川 華子, 川井田 みほ, 北川 雄光
- Publication Title
- Magazine name 膵臓 Publisher (一社)日本膵臓学会 Volume 34(Issue 1) Start Page 22 - End Page 29 (Publication Date）2019/02）
- ISSN
- 0913-0071
Epidermal Growth Factor Receptor Inhibition With Erlotinib in Liver: Dose De-Escalation Pilot Trial as an Initial Step in a Chemoprevention Strategy.
- Author
- Tanabe KK, Zahrieh D, Strand CA, Hoshida Y, Flotte TJ, Della'Zanna G, Umar A, Chavin KD, Cleary S, Kubota N, Llovet JM, Patel T, Siegel C, Limburg PJ
- Publication Title
- Volume 3(Issue 3) Start Page 426 - End Page 439 (Publication Date）2024）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2023/05）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2023/05）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2023/06）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2023/06）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2024/09）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2024/09）
Figure S1-S5 and Table S1 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2025/11）
Figure S1-S5 from Activating an Adaptive Immune Response with a Telomerase-Mediated Telomere Targeting Therapeutic in Hepatocellular Carcinoma
- Publication Title
- (Publication Date）2023/05）